Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3660690015 | Rizatriptan 5mg conventional release orodispersible tablet (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3660691016 | Rizatriptan 5mg conventional release orodispersible tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3660692011 | Rizatriptan 5mg orally disintegrating tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3762271011 | Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3762272016 | Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has BoSS | Rizatriptan | true | Inferred relationship | Some | 1 | |
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has presentation strength numerator value | 5 | false | Inferred relationship | Some | 1 | |
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has precise active ingredient | Rizatriptan benzoate | true | Inferred relationship | Some | 1 | |
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Is a | Rizatriptan only product in oromucosal dose form | false | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Is a | Rizatriptan only product in oral dose form | true | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has active ingredient | Rizatriptan benzoate | false | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has manufactured dose form | Orodispersible tablet | true | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Is a | Rizatriptan-containing product in oral dose form | false | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Is a | Product manufactured as oromucosal dose form | false | Inferred relationship | Some | ||
| Rizatriptan (as rizatriptan benzoate) 5 mg orodispersible tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian dialect reference set
FHIR